Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2030-2039
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2030
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2030
Figure 1 Survival and disease activity index scores.
A: Survival after dextran sulfate sodium (DSS) administration (n = 8, all tests were performed in triplicate); B: Disease activity index scores (which consider weight loss, stool consistency, and the extent of rectal bleeding) after DSS administration (n = 10, all tests were performed in triplicate). MSC: Mesenchymal stem cells.
- Citation: Nam YS, Kim N, Im KI, Lim JY, Lee ES, Cho SG. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World J Gastroenterol 2015; 21(7): 2030-2039
- URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2030.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2030